Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus

Int J Dermatol. 2017 Dec;56(12):1477-1479. doi: 10.1111/ijd.13713. Epub 2017 Aug 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Fatal Outcome
  • Female
  • Humans
  • Ipilimumab / therapeutic use*
  • Melanoma / complications
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Nivolumab / therapeutic use*
  • Pemphigus / complications*
  • Pemphigus / drug therapy
  • Prednisone / therapeutic use
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents, Immunological
  • Ipilimumab
  • Nivolumab
  • Prednisone